Clinical Nurse Specialist Program year 2021 Source: CMS Open Payments, 2026 publication

Christopher Footit

Registered Nurse, Psychiatric/Mental Health, Adult Hadley, MA Clinical Nurse Specialist

NPI 1447238126 CMS profile 10642265

8 River Dr, Hadley, MA 01035

Open in the dashboard

General payments

$489

27 records reported · program year 2021

Research payments

$0

Paid to them · None reported · program year 2021

Ownership & investment interest

$0

None reported

Through program year 2021, Christopher Footit of Hadley, MA is reported in the CMS Open Payments database as having received $489 across 27 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Registered Nurse, Psychiatric/Mental Health, Adult profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2021 General $489 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Footit
  • Registered Nurse, Psychiatric/Mental Health, Adult median
  • Middle half of Registered Nurse, Psychiatric/Mental Health, Adult
  • National median

In program year 2025, general payments to Christopher Footit were reported at $0. Among 96 Registered Nurse, Psychiatric/Mental Health, Adult profiles paid that year, the median was $121 and the middle half received between $39 and $265.

Show as a table
Year Christopher Footit Registered Nurse, Psychiatric/Mental Health, Adult median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $489 $108 $31–$328 $132
2022 $0 $99 $22–$306 $149
2023 $0 $99 $43–$313 $160
2024 $0 $119 $30–$319 $164
2025 $0 $121 $39–$265 $169

Breakdown

Who paid General payments · program year 2021
  1. AbbVie, Inc. $347 19 payments
  2. ITI, Inc. $47 1 payment
  3. Eisai Inc. $43 2 payments
  4. Sunovion Pharmaceuticals Inc. $35 4 payments
  5. Neurocrine Biosciences, Inc. $17 1 payment

Every payment, record by record

What the payments were for General payments · program year 2021
  1. Food and Beverage $443 26 payments
  2. Education $47 1 payment
Products named General payments · program year 2021
  1. VRAYLAR $347 19 payments
  2. CAPLYTA $47 1 payment
  3. Dayvigo $43 2 payments
  4. LATUDA $35 4 payments
  5. INGREZZA $17 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 39 drugs

Part D claims

1,760

Median for Certified Clinical Nurse Specialist: 344

Drug cost

$151,645

Median for Certified Clinical Nurse Specialist: $20,739

Branded share of claims

29%

Median for Certified Clinical Nurse Specialist: 20.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Austedo Deutetrabenazine Brand 13 $84,738
Trintellix Vortioxetine Hydrobromide Brand 31 $19,522
Vraylar Cariprazine Hcl Brand 12 $14,140
Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine Brand 83 $5,317
Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine Brand 192 $5,160
Bupropion Xl Bupropion Hcl Brand 52 $1,903
Duloxetine Hcl Generic 91 $1,806
Alprazolam Generic 143 $1,664
Lorazepam Generic 121 $1,616
Clonazepam Generic 195 $1,358

The 10 drugs with the highest cost, of 39 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,644 Part D prescribers listed as Certified Clinical Nurse Specialist; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 3 billing codes

Paid by Medicare

$13,571

Medicare's payments for the services billed

Medicare patients

66

Average age 62

Services billed

397

44 women, 22 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Depression 75%
High blood pressure 44%
Arthritis 39%
Diabetes 21%
Chronic kidney disease 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

27 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Registered Nurse, Psychiatric/Mental Health, Adult in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record